LTR Pharma Ltd (ASX: LTP) — Healthcare · Share Price, Chart & Market Data
About: LTR Pharma Limited, a clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. The company was incorporated in 2020 and is headquartered in Brisbane, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.43 (+10.26%)
LTPLTR Pharma Ltd
Loading watchlist status…
Trade LTP now
LTR Pharma Ltd share price
LTP price activity
Last Price
Change (24hr)
AUD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 1:12 pm GMT+0
LTP price performance
8.861%
5D
7.5%
1M
-39.437%
YTD
10.256%
1Y
LTP price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
ASX rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 1:12 pm GMT+0
LTP details
LTP Market Signals